Anatoliotaki Maria, Galanakis Emmanouil, Schinaki Athina, Stefanaki Sofia, Mavrokosta Maria, Tsilimigaki Amalia
Department of Paediatrics, Venizelion General Hospital, Heraklion, Crete, Greece.
Scand J Infect Dis. 2007;39(8):671-5. doi: 10.1080/00365540701199899.
The aim of the present study was to identify the organisms responsible for community acquired febrile UTI in children and to investigate their susceptibility to commonly used antibiotics. A 5-y prospective analysis was performed in children hospitalized for a first episode of UTI, in Crete, Greece. A total of 262 children, 40.1% males and 59.9% females, aged 0.08 to 13 y, were enrolled in the study. Escherichia coli (E. coli) was the leading uropathogen. Antimicrobial resistance of E. coli isolates was most commonly to ampicillin (56.4%) followed by trimethoprim-sulfamethoxazole (TMP-SMX) (27.3%), cefaclor (22.5%), amoxicillin-clavulanate (15.5%), gentamicin (4.9%), cefuroxime (3.1%), nitrofurantoin (2.6%), and ceftriaxone (1.6%). Interestingly, a significant decrease in E. coli resistance to TMP-SMX was observed during the study period. Resistance to ampicillin, TMP-SMX and cefaclor was noted for 61%, 28% and 27% of the total uropathogens, respectively, making these agents inappropriate for empirical treatment of febrile UTI in our region. A larger number of pathogens may be empirically treated with amoxicillin-clavulanate. More than 90% of the uropathogens are susceptible to cefuroxime, ceftriaxone, gentamicin, and nitrofurantoin. In conclusion, several of the first-line agents for empirical treatment of childhood UTI seem to have become ineffective in the area of this study.
本研究的目的是确定导致儿童社区获得性发热性尿路感染的病原体,并调查它们对常用抗生素的敏感性。在希腊克里特岛,对因首次尿路感染住院的儿童进行了为期5年的前瞻性分析。共有262名儿童参与了该研究,年龄在0.08至13岁之间,其中男性占40.1%,女性占59.9%。大肠埃希菌(大肠杆菌)是主要的尿路病原体。大肠杆菌分离株的耐药性最常见于氨苄西林(56.4%),其次是甲氧苄啶-磺胺甲恶唑(TMP-SMX)(27.3%)、头孢克洛(22.5%)、阿莫西林-克拉维酸(15.5%)、庆大霉素(4.9%)、头孢呋辛(3.1%)、呋喃妥因(2.6%)和头孢曲松(1.6%)。有趣的是,在研究期间观察到大肠杆菌对TMP-SMX的耐药性显著下降。分别有61%、28%和27%的尿路病原体对氨苄西林、TMP-SMX和头孢克洛耐药,这使得这些药物不适用于我们地区发热性尿路感染的经验性治疗。更多的病原体可以用阿莫西林-克拉维酸进行经验性治疗。超过90%的尿路病原体对头孢呋辛、头孢曲松、庆大霉素和呋喃妥因敏感。总之,在本研究区域,几种用于儿童尿路感染经验性治疗的一线药物似乎已经失效。